Avantor

Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards

Retrieved on: 
Thursday, March 16, 2023
SEAT, Drug development, International Fertilizer Development Center, Education, Chromatography, Government, ABEA, Avantor, Biotechnology, Acceleration, Fine chemical

Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables

Key Points: 
  • Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables
    Singapore, Mar 16, 2023 - (ACN Newswire) - Avantor, a leading global provider of mission-critical products and services to customers in the life sciences, education, government and advanced technologies & applied materials industries, has been accorded the Best Bioprocessing Company for Chromatography at the Asia-Pacific Bioprocessing Excellence Awards 2023 (ABEA).
  • With over four decades of experience in bioprocessing, Avantor is committed to addressing the complex challenges of downstream chromatography by providing a comprehensive range of equipment, products and services.
  • "Chromatography is one of the most important components in enabling scientific breakthroughs and bringing promising biologics to market effectively.
  • "We are exceptionally proud to have been selected by the panel of industry experts and honored at this year's ceremony as the Best Bioprocessing Company - Chromatography.

Avantor® to Present at Upcoming Investor Conferences

Retrieved on: 
Tuesday, February 28, 2023
Avantor, NYSE, Raymond James Financial, Webcast, AVTR, Raymond, Cowen

RADNOR, Pa., Feb. 28, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that management will present at two upcoming investor conferences.

Key Points: 
  • RADNOR, Pa., Feb. 28, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that management will present at two upcoming investor conferences.
  • Thomas Szlosek, Chief Financial Officer, will present at the Raymond James 44th Annual Institutional Investors conference in Orlando, Fla. on Monday, March 6 at 1:40 p.m. Eastern Standard Time.
  • Michael Stubblefield, President & CEO, will participate in a fireside chat at Cowen's 43rd Annual Health Care conference in Boston, Mass.
  • To hear live audio webcasts of these upcoming sessions, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com .

Avantor® Reports Fourth Quarter and Full-Year 2022 Results

Retrieved on: 
Friday, February 3, 2023
Education, EPS, Growth, Culture, Avantor, M&A, NYSE, Government, AVTR, COVID-19, EBITDA, Adjustment, GAAP, Pharmaceutical industry, Bookkeeping, Thermoplastic, Commercial property, Drug, Video game, Security (finance), Cryptocurrency

RADNOR, Pa., Feb. 3, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, today reported financial results for the fourth quarter and year ended December 31, 2022.

Key Points: 
  • "With fourth quarter results coming in line with expectations outlined on our third quarter earnings call, we realized core organic growth across all regions and delivered strong margin expansion despite ongoing macroeconomic pressures and customer destocking.
  • For the three months ended December 31, 2022, net sales were $1.80 billion, a decrease of 5.9% compared to the fourth quarter of 2021.
  • Operating cash flow in the quarter was $205.6 million, while free cash flow in the quarter was $172.0 million.
  • Net sales were $617.2 million, a reported decrease of 10.1%, as compared to $686.2 million in the fourth quarter of 2021.

Adam P. Crandall appointed Chief Revenue Officer by Addtronics Board of Directors

Retrieved on: 
Monday, January 30, 2023
Marketing, Dynamics, VWR International, Growth, Avantor, DDS, Family, Management

CHARLOTTE, N.C., Jan. 30, 2023 /PRNewswire/ -- Addtronics, LLC ("Addtronics"), a mission-driven holding company dedicated to acquiring, empowering, and growing leading robotic automation solution providers, announced today the appointment of Adam P. Crandall as Chief Revenue Officer effective January 1st, 2023.

Key Points: 
  • CHARLOTTE, N.C., Jan. 30, 2023 /PRNewswire/ -- Addtronics, LLC ("Addtronics"), a mission-driven holding company dedicated to acquiring, empowering, and growing leading robotic automation solution providers, announced today the appointment of Adam P. Crandall as Chief Revenue Officer effective January 1st, 2023.
  • In this newly created role, Adam will be responsible for all Addtronics commercial functions with the goal of accelerating growth and expanding market share.
  • Mr. Crandall previously led the commercial team at Dynamic Design Solutions, LLC ("DDS"), a member of the Addtronics family of companies.
  • Jerry Osborn, President of Addtronics stated, "I'm excited to bring Adam on board to lead our growing commercial organization.

Avantor® and Avantor Foundation Giving Supports Communities Around the Globe in 2022

Retrieved on: 
Wednesday, January 18, 2023
Education, Global Community Communications Alliance, HOPE, Engineering Development Trust, Laboratory, The Science of Good and Evil, Senior, NYSE, Organization, STEM, Health, Patient, Fortune 500, Research, Asthma, Goodness, Sustainability reporting, Pharmaceutical industry, Management, Avantor, Science

RANDOR, Pa., Jan. 18, 2023 /PRNewswire/ -- Avantor Foundation, the philanthropic arm of Avantor, Inc. (NYSE: AVTR), today announced that it has surpassed $7 million in giving since its inception in 2009, supporting its mission of advancing science education and providing healthcare to those in need. In 2022, the Foundation granted more than $1 million to 15 organizations around the world. In addition, Avantor Inc. donated products to support education and disaster relief efforts valued at more than $1.3 million.

Key Points: 
  • In 2022, the Foundation granted more than $1 million to 15 organizations around the world.
  • In addition, Avantor Inc. donated products to support education and disaster relief efforts valued at more than $1.3 million.
  • "We look forward to partnering with grantees and employees around the globe to extend our impact in 2023."
  • As part of Avantor's commitment to serving communities, Avantor Foundation recently expanded community engagement programming for Avantor employees to include matching gifts for both financial donations and volunteer time.

Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement

Retrieved on: 
Monday, January 9, 2023
Patient, NYSE, CTLT, Catalent, Science, Global health, Avantor

Under the terms of the agreement, Avantor will be the primary supplier of a broad range of laboratory supplies, clinical and production materials, and services to Catalent, expanding the companies' existing relationship.

Key Points: 
  • Under the terms of the agreement, Avantor will be the primary supplier of a broad range of laboratory supplies, clinical and production materials, and services to Catalent, expanding the companies' existing relationship.
  • "We look forward to deepening our work with the Avantor team to bring current and novel treatments to patients around the world."
  • "We are pleased to expand our support for Catalent and enable efficiencies to accelerate science for their customers around the globe."
  • This expanded relationship reflects Avantor's long history of providing customers with choice, reliability and innovative solutions.

MamaMancini’s Appoints Meghan Henson to Board of Directors

Retrieved on: 
Monday, December 19, 2022
Holding, Deli, University of Michigan, Jinan University, University of Wisconsin–Madison, Avantor, MBA, PepsiCo, CHRO, Ross School of Business, Learning, Policy, Culture, University, XPO Logistics, Political science, Management

EAST RUTHERFORD, NJ, Dec. 19, 2022 (GLOBE NEWSWIRE) -- MamaMancini's Holdings, Inc. (NASDAQ: MMMB), a leading national marketer and manufacturer of fresh Deli prepared foods, today announced the appointment of seasoned human resources (HR) executive Meghan Henson to its Board of Directors.

Key Points: 
  • EAST RUTHERFORD, NJ, Dec. 19, 2022 (GLOBE NEWSWIRE) -- MamaMancini's Holdings, Inc. (NASDAQ: MMMB), a leading national marketer and manufacturer of fresh Deli prepared foods, today announced the appointment of seasoned human resources (HR) executive Meghan Henson to its Board of Directors.
  • Meghan Henson is a senior executive with over 20 years of experience as a versatile human resources professional, leading HR strategy and execution at leading global organizations.
  • Ms. Henson is currently Executive Vice President and Chief Human Resources Officer (CHRO) at Avantor, a leading global provider of integrated, tailored solutions for the life sciences and advanced technology industries.
  • Ms. Henson was also a William Davidson Institute Fellow at Vietnam National Coal Corporation in Hanoi.

Avantor® to Report Fourth Quarter and Full Year 2022 Earnings and Host Earnings Call on Friday, February 3, 2023

Retrieved on: 
Friday, January 6, 2023
NYSE, Avantor, Webcast, Video game, Broadcasting

RADNOR, Pa., Jan. 6, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will release its fourth quarter and full year 2022 financial results before the market opens on Friday, February 3, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.

Key Points: 
  • RADNOR, Pa., Jan. 6, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it will release its fourth quarter and full year 2022 financial results before the market opens on Friday, February 3, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.
  • To hear a live audio webcast of the call, visit the " Events & Presentations " page of Avantor's website, www.avantorsciences.com , under the "Investors" section.
  • A replay of the webcast and related presentation materials will be available for 30 days.

Avantor® to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Tuesday, January 3, 2023
Fortune 500, Health, Laboratory, Science, Avantor, Research, Webcast, NYSE, Conference, Management

To hear a live audio webcast of the presentation, visit the " Events & Presentations " page of Avantor's website, www.avantorsciences.com , under the "Investors" section.

Key Points: 
  • To hear a live audio webcast of the presentation, visit the " Events & Presentations " page of Avantor's website, www.avantorsciences.com , under the "Investors" section.
  • A replay of the webcast will be available for 30 days.
  • Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
  • Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve.

Single-Use Assemblies Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Friday, December 9, 2022
Water, Particulates, Thermo Fisher Scientific, Repligen Corporation Award in Chemistry of Biological Processes, Filtration, Pall Corporation, HIV, Saint-Gobain, Research report, Avantor, AMRC, Corning Inc., Parker Hannifin, Vacuum, Research, Sartorius AG, Danaher Corporation, Merck Group, Infection, COVID-19, Growth, Vaccine, HPLC, Acquisition, Medical research, GE Healthcare, Organization, Medical device, Fine chemical

The single-use assemblies market is expected to grow to $8.73 billion in 2026 at a compound annual growth rate (CAGR) of 20.7%.

Key Points: 
  • The single-use assemblies market is expected to grow to $8.73 billion in 2026 at a compound annual growth rate (CAGR) of 20.7%.
  • The main types of single-use assemblies market products are filtration assemblies, bag assemblies, bottle assemblies, and mixing system assemblies.Filtration assemblies are used for tissue culture media, biological fluids, High-Performance Liquid chromatography (HPLC), and other aqueous solutions vacuum filtered.
  • The regions covered in single-use assemblies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The single-use assemblies market research report is one of a series of new reports that provides single-use assemblies market statistics, including single-use assemblies industry global market size, regional shares, competitors with an single-use assemblies market share, detailed single-use assemblies market segments, market trends and opportunities, and any further data you may need to thrive in the single-use assemblies industry.